Biotechnology

5 Rev ed
ISBN: 978-0-521-88494-5
Verlag: Cambridge University Press

Buch, Englisch, 278 Seiten, Format (B × H): 189 mm x 246 mm, Gewicht: 760 g

Biotechnology is the major technology of the 21st century, yet few people realise how much it impacts on many aspects of human society. The defining aim of this new fifth edition is to re-establish the correct understanding of the term biotechnology. Using the straightforward style that made the previous editions of his textbook so popular, John Smith once again helps students with the deciphering and use of biological knowledge. He explains the historical developments in biotechnology and the range of activities from brewing beer, the treatment of sewage and other wastes, and the creation of biofuels. He also discusses the innovations in molecular biology, genomics and proteomics, systems biology and their impact on new biotechnology. In this edition John Smith also re-examines the ethics and morality of aspects of biotechnology and puts new emphasis on stem cells and regenerative medicine and micro RNA.

Autoren/Hrsg.

Smith, John

Smith, John E.

Fachgebiete

• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie

Inhaltsverzeichnis

1. The nature of biotechnology; 2. Biomass: a biotechnology substrate?; 3. Genetics and biotechnology; 4. Bioprocess/fermentation technology; 5. Enzyme technology; 6. Biological fuel generation; 7. Environmental biotechnology; 8. Plant and forest biotechnology; 9. Animal and insect biotechnology; 10. Food and beverage biotechnology; 11. Biotechnology and medicine; 12. Stem cell biotechnology; 13. Protection of biotechnological inventions; 14. Safety in biotechnology; 15. Public perception of biotechnology: genetic engineering - safety, social, moral and ethical considerations; 16. Looking to the future.

Über Autor(innen)

Smith, John E.
John E. Smith is Emeritus Professor of Applied Microbiology in the Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow and Chief Scientific Adviser to GlycaNova, Norway.